Aspirin As Secondary Prevention in Patients With Colorectal Cancer: An Unselected Population-Based Study.
about
Tailored Treatment of Colorectal Cancer: Surgical, Molecular, and Genetic Considerations.Development and validation of risk prediction equations to estimate survival in patients with colorectal cancer: cohort studySystemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-matched Analysis.HspB5 correlates with poor prognosis in colorectal cancer and prompts epithelial-mesenchymal transition through ERK signaling.Examining the impact of regular aspirin use and PIK3CA mutations on survival in stage 2 colon cancer.Functio Laesa: Cancer Inflammation and Therapeutic Resistance.Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival.Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort Study.The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.Drug Repurposing for the Treatment of Acute Myeloid Leukemia.Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases.Systematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients?Aspirin associated with risk reduction of secondary primary cancer for patients with head and neck cancer: A population-based analysis
P2860
Q33574744-BA9D9427-68EB-4D79-BAF5-A18EB6B09B83Q33801777-8A0E8E66-7C17-431E-B074-EEFBBD6F7A01Q37522481-0A44EB93-8CB7-4F77-9C3A-33C83DBE39B4Q38630418-43B70AFA-EFCE-4F0E-B8E1-783FBD8C365CQ38995724-510720D4-9300-4CC4-9FEA-A15606B9EEB9Q39172861-B6313753-EFFC-4E25-BDEA-05AFB0114CD2Q40159079-E302C4C0-9211-4DA7-A46F-2A3DF79FFF0AQ40225671-DBA34A3A-9359-4FCC-8924-3C74312D5E09Q40509254-5C12F142-B376-492F-914C-2AFBFD968DBEQ47094576-013EF33A-9AC1-42D6-B3B4-456BD387DC77Q48247468-FEF9E195-1503-4A4D-B67A-083CAA2D2A3AQ58699234-EE31F6E9-66BB-4DE5-9A1D-AD2B506329EBQ58723469-7F7529CF-E563-46FD-8424-487B0441428B
P2860
Aspirin As Secondary Prevention in Patients With Colorectal Cancer: An Unselected Population-Based Study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Aspirin As Secondary Preventio ...... lected Population-Based Study.
@en
Aspirin As Secondary Preventio ...... lected Population-Based Study.
@nl
type
label
Aspirin As Secondary Preventio ...... lected Population-Based Study.
@en
Aspirin As Secondary Preventio ...... lected Population-Based Study.
@nl
prefLabel
Aspirin As Secondary Preventio ...... lected Population-Based Study.
@en
Aspirin As Secondary Preventio ...... lected Population-Based Study.
@nl
P2093
P50
P356
P1476
Aspirin As Secondary Preventio ...... lected Population-Based Study.
@en
P2093
Bjørn Atle Bjørnbeth
Bjørn Møller
Liv Marit Dørum
Milada Mahic
Simer J Bains
Tor Åge Myklebust
P304
P356
10.1200/JCO.2015.65.3519
P407
P577
2016-05-31T00:00:00Z